Hair Loss as a Side Effect of GLP-1 Medications

Approximately 20 million individuals in the US, UK, and EU are currently using GLP-1 receptor agonists, such as tirzepatide and semaglutide (more commonly known by brand names like Ozempic or Mounjaro), for weight loss and managing type 2 diabetes. With the rise in their usage, attention has turned to various side effects, one of which has recently garnered significant interest: hair loss.

A survey indicated that around 20% of those taking these medications reported some degree of hair shedding. However, the scarcity of robust data from randomized controlled trials leaves us uncertain about how frequent this side effect truly is.

While hair loss associated with GLP-1 medications is often temporary and reversible, it’s impactful enough that some patients hesitate to take drugs that might otherwise be beneficial for them. Here’s a closer look at the situation.

Types of Hair Loss Observed with GLP-1 Use

Most GLP-1 users do not face hair loss issues, yet those who do may start to notice changes within the first year, typically peaking just before the 12-month mark.

According to Lynn Petukhova, a geneticist studying hair loss at New York University, individuals experiencing this side effect usually fall into one of two categories. The more common type is telogen effluvium, a stress-induced condition where a significant portion of hair follicles enter a resting phase. During this phase, hair growth halts, leading to shedding roughly two to three months later. Fortunately, this type of hair loss tends to be temporary, and normal growth resumes once the stressor is removed.

A smaller group of individuals may experience new or heightened pattern baldness, characterized by a receding hairline in men or widening parts in women. In Petukhova’s recent study, men using GLP-1 drugs had a 7% increased likelihood of experiencing this form of hair loss compared to their untreated counterparts, although the study did not assess the risk for women due to less understanding of the genetic factors involved.

Interestingly, hair loss experiences can differ based on hair type. Research has shown that white patients often report shedding and thinning, while Black patients more frequently describe dryness and breakage.

Causes of Hair Loss Linked to GLP-1 Medications

In the context of rapid weight loss, the causes of telogen effluvium can stem from either extreme calorie restriction or deficiencies in micronutrients due to reduced food intake.

The specific medication and its dosage also play a role, with those on higher doses of tirzepatide and semaglutide observing the highest occurrences of temporary hair loss.

Additionally, nearly 90% of those reporting telogen effluvium while on GLP-1 drugs are women. This condition is similarly common after childbirth, often linked to drastic hormonal shifts. It’s also worth noting that about 60% of patients may face hair loss following weight loss surgery.

The mechanisms behind pattern baldness in users of GLP-1 medications remain less understood but may involve a genetic connection between the drug’s response and the predisposition to this type of hair loss. “Some individuals carry a higher genetic risk,” Petukhova explains, suggesting the drug may reveal underlying susceptibilities.

Managing Hair Loss While Using GLP-1 Drugs

If you’re contemplating the initiation of a GLP-1 medication, discussing the potential for hair loss with your healthcare provider is advisable.

Because hair follicles react sensitively to certain nutritional deficits, ensuring an adequate intake of protein and key minerals like iron, zinc, and biotin can be beneficial. Nonetheless, these measures aren’t foolproof, especially during periods of rapid weight loss. Opting for lower doses and a gradual weight loss approach may also help mitigate risks.

For those already experiencing hair loss, consulting a general practitioner or dermatologist is wise—their expertise can help determine if the loss is likely temporary or permanent, guiding appropriate treatment options. As mentioned, temporary hair loss can often be reversed with improved nutrition and a bit of time. For those facing pattern hair loss, treatments like minoxidil and finasteride might provide some relief.

If you’re prescribed a GLP-1 medication but worry about potential side effects, including hair loss, it’s vital to have that discussion with your doctor. Cosmetic concerns should not overshadow the more crucial aspects of health management, Petukhova emphasizes. “For many people, regulating metabolic health should take precedence over maintaining hair,” she advises.